PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
The Korean Journal of Urological Oncology10.22465/kjuo.2022.20.1.12202220112-24New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder CancerJaewoon Jeong, Jae Baek Ha, In Ho Changhttp://kjuo.or.kr/upload/pdf/kjuo-20-1-12.pdf, http://kjuo.or.kr/journal/view.php?doi=10.22465/kjuo.2022.20.1.12, http://kjuo.or.kr/upload/pdf/kjuo-20-1-12.pdf
Investigative and Clinical Urology10.4111/icu.20200602202162Emerging treatments for bacillus Calmette–Guérin-unresponsive non-muscle-invasive bladder cancerHyung Suk Kim, Ho Kyung Seohttps://icurology.org/pdf/10.4111/icu.20200602, https://icurology.org/DOIx.php?id=10.4111/icu.20200602, https://icurology.org/DOIx.php?id=10.4111/icu.20200602
Bladder Cancer10.3233/blc-150015201512105-116Bacillus Calmette-Guérin (BCG) Treatment Failures in Non-Muscle Invasive Bladder Cancer: What Truly Constitutes Unresponsive DiseaseRyan L. Steinberg, Lewis J. Thomas, Michael A. O’Donnellhttps://content.iospress.com/download?id=10.3233/BLC-150015
Urological Science10.1016/j.urols.2015.04.0052015262101-102Editorial comment on “Maintenance bacillus Calmette-Guérin therapy for nonmuscle-invasive bladder cancer: A need for more randomized trials”Shu-Pin Huanghttp://api.elsevier.com/content/article/PII:S1879522615000652?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S1879522615000652?httpAccept=text/plain
Cancer10.1002/cncr.2362720081134710-716Maintenance bacillus Calmette-Guérin in high-risk nonmuscle-invasive bladder cancerMarc Decobert, Hélène LaRue, François Harel, François Meyer, Yves Fradet, Louis Lacombehttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.23627, https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.23627
Bladder Cancer10.3233/blc-150039201622215-224Bacillus Calmette-Guérin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive DiseaseRyan L. Steinberg, Lewis J. Thomas, Sarah L. Mott, Michael A. O’Donnellhttps://content.iospress.com/download?id=10.3233/BLC-150039
Journal of Urology10.1016/j.juro.2013.06.03020131903832-833The Challenge of Bacillus Calmette-Guérin Failure in Nonmuscle Invasive Bladder Cancer—What is the Next Step in Management?Yair Lotanhttps://api.elsevier.com/content/article/PII:S0022534713046272?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0022534713046272?httpAccept=text/plain, http://www.jurology.com/doi/pdf/10.1016/j.juro.2013.06.030
Clinical Genitourinary Cancer10.1016/j.clgc.2017.10.0192018163e587-e593Intravesical Immunomodulatory Imiquimod Enhances Bacillus Calmette-Guérin Downregulation of Nonmuscle-invasive Bladder CancerJuliana A. Camargo, Gabriela R. Passos, Karen L. Ferrari, Athanase Billis, Mário J.A. Saad, Leonardo O. Reishttps://api.elsevier.com/content/article/PII:S155876731730335X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S155876731730335X?httpAccept=text/plain
European Urology Focus10.1016/j.euf.2021.09.0052021Sequential Gemcitabine plus Docetaxel Is the Standard Second-line Intravesical Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle invasive Bladder Cancer: ConElisabeth Grobet-Jeandin, Ugo Pinar, Morgan Rouprêthttps://api.elsevier.com/content/article/PII:S2405456921002339?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2405456921002339?httpAccept=text/plain
Urology Practice10.1016/j.urpr.2017.02.012201852132-138Association between Metabolic Syndrome and Recurrence of Nonmuscle Invasive Bladder Cancer following bacillus Calmette-Guérin TreatmentAndrew T. Lenis, Kian Asanad, Maher Blaibel, Nicholas M. Donin, Karim Chamiehttps://api.elsevier.com/content/article/PII:S2352077917300456?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2352077917300456?httpAccept=text/plain, http://www.jurology.com/doi/pdf/10.1016/j.urpr.2017.02.012